Search details
1.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38587237
2.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38587254
3.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.
Circulation
; 149(21): 1627-1638, 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38581389
4.
World Stroke Organization Brain & hEart globAl iniTiative Program.
Cerebrovasc Dis
; 53(1): 115-124, 2024.
Article
in English
| MEDLINE | ID: mdl-37276846
5.
Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial.
Am Heart J
; 265: 132-136, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37506747
6.
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 143(12): 1215-1223, 2021 03 23.
Article
in English
| MEDLINE | ID: mdl-33461308
7.
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med
; 380(16): 1509-1524, 2019 04 18.
Article
in English
| MEDLINE | ID: mdl-30883055
8.
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.
Circulation
; 139(20): 2292-2300, 2019 05 14.
Article
in English
| MEDLINE | ID: mdl-30773022
9.
Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).
J Stroke Cerebrovasc Dis
; 29(9): 104938, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32807412
10.
Sex Disparities in Cardiology: How Are We Doing in Latin America?
Circulation
; 147(7): 521-522, 2023 02 14.
Article
in English
| MEDLINE | ID: mdl-36780382
11.
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
Lancet
; 390(10104): 1737-1746, 2017 Oct 14.
Article
in English
| MEDLINE | ID: mdl-28859942
12.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Lancet
; 389(10081): 1799-1808, 2017 May 06.
Article
in English
| MEDLINE | ID: mdl-28325638
13.
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
Am Heart J
; 197: 133-141, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29447773
14.
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Circulation
; 132(8): 624-32, 2015 Aug 25.
Article
in English
| MEDLINE | ID: mdl-26106009
15.
First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina.
Stroke
; 47(6): 1640-2, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27217510
16.
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
Am Heart J
; 175: 175-83, 2016 May.
Article
in English
| MEDLINE | ID: mdl-27179738
17.
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Am Heart J
; 169(1): 25-30, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25497244
18.
Apixaban versus warfarin in patients with atrial fibrillation.
N Engl J Med
; 365(11): 981-92, 2011 Sep 15.
Article
in English
| MEDLINE | ID: mdl-21870978
19.
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Am Heart J
; 168(3): 303-9, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25173541
20.
Thrombin as target for prevention of recurrent events after acute coronary syndromes.
Thromb Res
; 235: 116-121, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38335566